Related Experiment Video
Updated: Aug 19, 2026

Biochemical Measurement of Neonatal Hypoxia
Published on: August 24, 2011
Plasma cholinesterase deficiency in a neonate
C A Pasquariello1, R E Schwartz
1Department of Anesthesia and Critical Care, Temple University School of Medicine, Philadelphia, Pennsylvania.
Abstract:
We report a two-day-old infant who had a period of apnoea lasting six hours following the intravenous administration of succinylcholine (Sch). The results of her plasma cholinesterase level and dibucaine number indicate a congenital absence of plasma cholinesterase (PChE) enzyme, although both parents and siblings had normal cholinesterase levels and dibucaine numbers. This is believed to be the youngest reported case of prolonged apnoea after the administration of succinylcholine.
Related Concept Videos
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Cholinesterases: Distribution and Function
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Depolarizing Blockers: Pharmocokinetics

